文献速递瓣膜病与结构性心脏病

主动脉瓣狭窄结构与功能改变分期与TAVR预后相关

Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.
PubMed 文献 · JAMA Cardiol · 2019-01-01

该队列分析纳入689例在匹兹堡大学医学中心接受TAVR的重度主动脉瓣狭窄患者,评估基于超声心动图的结构与功能改变分期与TAVR术后全因死亡及再入院的关系。结果显示,校正STS-PROM后,分期与全因死亡率呈分级关联,3期和4期患者死亡风险显著高于1期,3期患者心脏原因再入院率也更高。

要点

  • 主动脉瓣狭窄分期与TAVR术后全因死亡率呈分级关联。
  • 3期和4期患者全因死亡风险显著高于1期。
  • 3期患者心脏原因再入院风险更高。

核心结论

  • 主动脉瓣狭窄分期与TAVR术后全因死亡率呈强分级关联,可能改善风险分层与预后评估。

研究设计与样本

  • 队列分析,纳入2011年7月1日至2017年1月31日在匹兹堡大学医学中心接受TAVR的689例重度主动脉瓣狭窄患者,排除瓣中瓣手术及基线超声心动图不完整者。

主要发现

  • 分期患病率:1期13%,2期62%,3期21%,4期4%。

关键数值与推荐

  • 1期:左心室质量指数增加、E/e'>14、左心室射血分数<50%;2期:左心房容积指数>34 mL/m2、中重度二尖瓣反流、心房颤动;3期:肺动脉收缩压≥60 mm Hg、中重度三尖瓣反流;4期:中重度右心室功能障碍。

临床怎么用

  • 对重度主动脉瓣狭窄患者行TAVR术前,可依据超声心动图分期评估心脏结构与功能改变程度,辅助风险分层与预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Severe aortic stenosis causes pressure overload of the left ventricle, resulting in progressive cardiac dysfunction that can extend beyond the left ventricle. A staging system for aortic stenosis has been recently proposed that quantifies the extent of structural and functional cardiac changes in aortic stenosis. OBJECTIVES: To confirm the reproducibility of a proposed staging system and expand the study findings by performing a survival analysis and to evaluate the association of aortic stenosis staging with both cardiac and noncardiac post-transcatheter aortic valve replacement (TAVR) readmissions. DESIGN, SETTING, AND PARTICIPANTS: A cohort analysis was conducted involving patients with severe aortic stenosis who underwent TAVR at the University of Pittsburgh Medical Center between July 1, 2011, and January 31, 2017. Patients who had undergone TAVR for valve-in-valve procedures and had an incomplete or unavailable baseline echocardiogram study for review were excluded. Clinical, laboratorial, and procedural data were collected from the Society of Thoracic Surgeons database and augmented by electronic medical record review. EXPOSURES: The aortic stenosis staging system is based on echocardiographic markers of abnormal cardiac function. The stages are as follows: stage 1 (left ventricle changes - increased left ventricular mass index; early mitral inflow to early diastolic mitral annulus velocity (E/e') >14; and left ventricular ejection fraction <50%), stage 2 (left atrial or mitral changes - left atrial volume index >34 mL/m2; moderate to severe mitral regurgitation; and atrial fibrillation), stage 3 (pulmonary artery or tricuspid changes - pulmonary artery systolic pressure ≥60 mm Hg; moderate to severe tricuspid regurgitation), and stage 4 (right ventricle changes - moderate to severe right ventricle dysfunction). MAIN OUTCOMES AND MEASURES: Primary outcome was post-TAVR all-cause mortality. Secondary outcomes were composite outcomes of all-cause mortality and post-TAVR all-cause and cardiac-cause readmissions. RESULTS: A total of 689 consecutive patients (351 [50.9%] were male, with a mean [SD] age of 82.4 [7.6] years) were included. The prevalence of stage 1 was 13%; stage 2, 62%; stage 3, 21%; and stage 4, 4%. Patients with higher staging had a greater burden of comorbidities as captured by the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM). Despite adjustment for STS-PROM, a graded association was found between aortic stenosis staging and all-cause mortality (hazard ratio [HR] stage 2 vs stage 1: 1.37 [95% CI, 0.81-2.31; P = .25]; stage 3 vs stage 1: 2.24 [95% CI, 1.28-3.92; P = .005]; and stage 4 vs stage 1: 2.83 [95% CI, 1.39-5.76; P = .004]). Stage 3 patients had higher post-TAVR readmission rates for both cardiac (HR, 1.84; 95% CI, 1.13-3.00; P = .01) and noncardiac causes. CONCLUSIONS AND RELEVANCE: Aortic stenosis staging appears to show a strong graded association between the extent of cardiac changes and post-TAVR all-cause mortality; such staging may improve patient care, risk stratification, assessment of prognosis, and shared decision making for patients undergoing TAVR.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Fukui M, Gupta A, Abdelkarim I, et al. Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis. JAMA Cardiol. 2019. PMID: 30725109. doi:10.1001/jamacardio.2018.4830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。